Rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs).
Developing the next generation of rapid diagnostic products to meet the market need for simple to use, rapid, cost effective, portable systems.
We offer a complete integrated solution for the development and manufacturing of lateral flow products and reader systems.
Commercial partners required for nucleic acid lateral flow immunoassay, PCRD https://t.co/L7HdhP0oA8 #NALFIA Meet u… https://t.co/FYclTYjxlc
20 October 2016
© Abingdon Health 2016